Antibodies specifically binding to MASP-3 for the treatment of various diseases and disorders
US11883493B2 · kind B2 · utility
0Cited by
16References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2021 |
| Grant date | Jan 30, 2024 |
| Priority date | — |
| Expiry date | Jan 15, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to MASP-3 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-3 dependent complement activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.